��Leveraging the learnings from Covid-19 vaccination for Routine Immunization
Outline
COVID-19 VACCINATION COVERAGE
More than 219.95 crore total doses administered by Nov 22
Eligible Population 12-14 years | ||
Doses Administered | 1st dose 41.3 million (88%) | 2nd dose 32.5 million (69%) |
Eligible Population 15-18 years | |
1st dose 62.0 million (84%) | 2nd dose 53.4 million (72%) |
Eligible Population 18 years and above | |
1st dose 922.1 million (98%) | 2nd dose 864.7 million (92%) |
COVID-19 vaccine is made available free of cost for all citizens of the country aged 12 years and above, irrespective of their socio-economic status, at all Government COVID-19 Vaccination Centres (CVCs). In addition this vaccine is also available in the private market in order to address to access to entire country.
Data Source – Co-WIN as of Nov 2022
Early action and response
30 Jan20 India's first Case reported
19 April 2020 GOI sets up a high level task force for COVID-19 vaccine development
5 May 2020 PM Chairs a meeting of task force
30 June 2020 Covaxin approved for Phase I & II human clinical trials
Oxford University-Astra Zeneca COVID-19 vaccine (Covishield) approved for phase II + III clinical trials in India
29 November 2020 GOI announces third stimulus package of Rs. 900 crores for the Mission COVID Suraksha- The Indian COVID-19 Vaccine Development Mission
1 January 2021 Covishield approved for restricted use in emergency situations
2 January 2021 Covaxin approved for restricted use in emergency situations
Initiated the preparedness of Health System to respond to all aspect of COVID-19 Management
National Expert Group on Vaccine Administration for COVID-19 (NEGVAC), constituted in August 2020, to formulate comprehensive action plan for vaccine administration
Trail runs for conducting Vaccination as per guidelines and use of CoWIN carried out
Operational guideline of Covid-19 vaccination was issued in December 2020.
5
Block
Control Room (BCR)
State Control Room (SCR)
District / Municipal
Control Room (DCR)
State Level
District Level
Block Level
NEGVAC
National Expert Group on Vaccine Administration for COVID-19
Urban Task Force (UTF)
Chair: Municipal Commissioner
State Steering Committee (SSC)
(Chair: Chief Secretary)
District Task Force (DTF)
(Chair: District Collectors)
Block Task Force (BTF)
(Chair: SDM/ Tehsildar/ BDO)
State Task Force (STF)
(Chair: Principal Secretary Health)
Role of government departments, partners, professional organizations and other stake holders defined
Governance and Coordination Mechanism
Prioritization for Vaccine Administration by NEGVAC – based on Scientific Evidence & Global Best Practices
Vaccination for lactating mothers approved on 19th May, 2021 and of pregnant women on 2nd July, 2021
16th Jan 2021
1st Mar 2021
1st May 2021
2nd Feb 2021
21st June 2021
10th Jan 2022
3rd Jan 2022
Health Care
Workers
Aged ≥60 years & �45 – 59 years with identified 20 co-morbidities
Persons aged 18 years & above (In Pvt sector/ State’s prioritization)
Adolescents aged 15-18
Phase 1
Phase 4
Phase 2
Phase 3
Phase 5
Front Line
Workers
All persons aged ≥ 45 years
1st Apr 2021
Free vaccination to all persons aged 18 years & above
Precaution doses for HCW, FLW and 60yrs+ population with Co-morbidities
16th Mar 2022
Phase 6
Children aged 12 to 14 years
&
Precaution dose for all persons aged ≥60 years
Phase 7
10th Apr 2022
Free Precaution dose for all persons aged ≥18 years at Govt. CVCs
Free Precaution dose for all persons aged ≥ 60 years
(paid for 18-59yrs in Pvt CVCs)
15th Jul 2022
Operational Guidelines shared with States/UTs
Capacity building for Covid-19 vaccination
Streamlining supply chain
Equitable distribution
Initially on demand, later on rate of vaccination and target population
Daily review with vaccine manufacturer
Reducing dead stock at every level including manufacturer
Batch wise Supply Schedule with advance visibility for one month
Supplies made to states almost every day.
From December 2021 supplies made only on demand by State/UTs
Principles of Covid-19 vaccine Supply Chain
WHERE ARE MY VACCINES ?
ARE THEY STORED IN ADEQUATE QUANTITIES ?
ARE THEY STORED AT
RECOMMENDED TEMPERATURES ?
Smartphone App
Online Dashboard
Temperature Logger
Easy-to-use mobile app
for recording vaccine data
Web interface for
real-time visibility
Temperature loggers for accurate remote
temperature monitoring in real time
3 Critical Questions for Vaccine Supply Chain
Pre-empting the need, eVIN expanded from 24 to 36 States/UTs
Phases of Covid Vaccine supply
Supplies to State/UTs on demand
Demand > production per month
Demand < production per month
Stock piling by States/UTs as supplies > utilisation
Production per month
Covishield 25-30 crore
Covaxine 5-6 crore
Production per month
Covishield 1 crore
Covaxine 0.25 crore
Production increase over period. Also more covid vaccine type added to pool
Consistent Efforts Achieving Major Milestones
9 months
9 months
> 2.5 crore doses administered in a day on 17th Sept’21
Learnings from Covid-19 vaccination to RI
To capitalize on COVID-19 vaccination investments, innovations, and new tools to strengthen and re-imagine routine immunization
I. CoWIN : THE DIGITAL BACKBONE FOR THE COVID-19 VACCINATION PROGRAM
Leveraging CoWIN for RI strengthening
Equitable and Inclusive
Single Source of Truth
Evolvability and Scalability
Feedback and Analysis
Citizen centric
Open and interoperable
KEY ATTRIBUTES OF CoWIN
The platform is currently in the progress of being leveraged for routine immunization
Key take away from CoWIN
Existing database
Age and sex-wise database: Esp. useful for new vaccine introduction like for HPV (9-14y girls)
Co-WIN already has a database of 12-14y girls, only 9-11y database needs to be updated
Healthcare professionals and health facilities
Citizen centric model
Blended Registration and Convenience in Slot Booking
Track Vaccination Schedule
Instant Digital Certificate
Advisories for a People-Centric Vaccination Programme
Digitally Signed
Single Source of Truth
Offline-Verifiable
Key take away from CoWIN
Tackling digital divide and low internet connectivity
-Self registration and Toll-free helpline no. to book appointment
-Linkages with different platforms
-HWs can upload in real time as well as with flexibility in low network areas
Uniform access across private and public, fixed or mobile
-Vaccine Stock Management and equitable consumption
-Realtime Dashboards
Coverage, maps etc
-Robust System
handles a
billion+ visits daily
CoWIN dashboard and data visualization
Features provided by Dashboard
Accessible by all
Policy Makers
State & District Administrators
All Citizens and foreign entities
Hospitals
Vaccinators
II. Demand generation and community engagement
Strengthening partnerships and engagement of trusted community representatives and community-based networks for demand generation and uptake
Helpline number 181,Chhattisgarh
AIIMS Bhatinda,
Punjab
Border Security Force, Punjab
Camel cart –
Rajasthan
Tea Gardens,
Assam
Boat for
awareness
Mobile Vaccination Units – Vaccine Express
Influencer Engagement
Vaccination of Madrasa students in Asia’s biggest Masjid, compound, Bhopal
Facilitating vaccination of “person with disability” by volunteer of Pingalwada Ashram, Punjab
Partnership with Missionaries of charity for vaccination, Madurai, Tamil Nadu
Faith-Based Leader engaged for vaccination, Assam
Engagement of faith-based organizations, religious groups and community influencers for mobilization to address vaccines hesitancy and build community trust in COVID-19 Vaccination
II. Demand generation and community engagement
18
Collaboration with a religious organization in Madhya Pradesh
Transgender vaccination in Tamil Nadu with help of local community group
Vaccination of Salt Pan workers in Tamil Nadu
Senior Citizens – Self Help Groups
Children engagement
Community-driven engagement
Active engagement with members from within communities for generating awareness about COVID-19 Vaccination
II. Demand generation and community engagement
III. Opportunity to leverage various assets for RI
Just prior to Covid-19 vaccination introduction, Pan India scale up of e-VIN from 24 to all 36 States/UTs
Strengthening cold chain space to handle volume of Covid-19 vaccines over and above RI vaccines
Connectivity of remotest areas and hard-to-reach areas to health infrastructure
Augmented workforce e.g.: staff nurses from medical colleges was used and can may be leveraged for future exigency also
Implementation of SoPs for supply chain
-Demand-based or consumption-based supplies
Integration of SAFE-VAC with CoWIN for AEFI reporting
III. Opportunity to leverage various assets for RI
Strengthened governance model for citizen centric policies
Quick and continuous updation of guidelines based on emerging evidence
Intersectoral convergence with ‘other’ 19 Ministries
Capacitated Health workers for blended modality of training (offline + online) of learning
Alternate vaccine delivery in hard-to-reach and inaccessible terrain
(e.g. drones tested in 2 states)
Better informed community on importance of vaccination
Partnerships beyond traditional partners
| Thank you |